1.35 m babies are born with a congenital heart defect each year. Of these, 400,000 have heart valve defects, but there is no durable valve replacement on the market! We are fulfilling that unmet clinical need with a completely new prosthetic valve for adults and children, implanted using a low-risk transcatheter technique. Our valve is made from patient-donated (endogenous) tissue, giving it lifelong durability: a once-in-a-lifetime solution that is affordable for patients and healthcare providers worldwide.
Learn moreGrOwnValve is a pre-clinical stage medical device company, developing a unique heart valve prosthesis system. The first product, the AdultValve and the second product, the ChildValve including a bioresorbable anchoring device will come to market as a procedure pack that enables a safe, affordable and easy-to-use minimally invasive heart valve replacement made from the patient’s own tissue.
Our main goal is to offer a lifelong cure to patients with heart valve defects worldwide. Our innovation eliminates the need for repeated heart valve replacement surgery and lifelong medication.
paediatric cardiology
business administration
engineer biotechnology
paediatric cardiologist, clinical trial
paediatric cardiac surgeon, clinical trial
regulatory compliance and quality control
cardiac surgeon
engineer 3D technology
toxicologist
technicial documentation
medical doctorate
GrOwnValve GmbH
Sredzkistr. 6
10435 Berlin